Understanding the mechanism of improved CFR after TAVR/SAVR - the importance of basal flow
- PMID: 36861264
- PMCID: PMC9936251
- DOI: 10.4244/EIJ-E-22-00052
Understanding the mechanism of improved CFR after TAVR/SAVR - the importance of basal flow
Conflict of interest statement
M.J. Kern is a speaker for Abbott Vascular, Boston Scientific, ACIST Inc, and OpSens Inc. A.H. Seto has research grants from Philips and ACIST; honoraria from Getinge, General Electric, and Terumo, and equity in Frond Medical.
Figures

References
-
- Sabbah M, Joshi FR, Minkkinen M, Holmvang L, Tilsted H-H, Pedersen F, Ahtarovski K, Sørensen R, Thue Olsen, Søndergaard L, De Backer, Engstrøm T, Lønborg J. Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation. Circ Cardiovasc Interv. 2022;15:e011331. - PubMed
-
- Ahmad Y, Götberg M, Cook C, Howard JP, Malik I, Mikhail G, Frame A, Petraco R, Rajkumar C, Demir O, Iglesias JF, Bhindi R, Koul S, Hadjiloizou N, Gerber R, Ramrakha P, Ruparelia N, Sutaria N, Kanaganayagam G, Ariff B, Fertleman M, Anderson J, Chukwuemeka A, Francis D, Mayet J, Serruys P, Davies J, Sen S. Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: Implications for Clinical Indices of Coronary Stenosis Severity. JACC Cardiovasc Interv. 2018;11:2019–31. - PMC - PubMed
-
- Patterson T, Clayton T, Dodd M, Khawaja Z, Morice MC, Wilson K, Kim WK, Meneveau N, Hambrecht R, Byrne J, Carrié D, Fraser D, Roberts DH, Doshi SN, Zaman A, Banning AP, Eltchaninoff H, Le Breton, Smith D, Cox I, Frank D, Gershlick A, de Belder, Thomas M, Hildick-Smith D, Prendergast B, Redwood S ACTIVATION Trial Investigators. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial. JACC Cardiovasc Interv. 2021;14:1965–74. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources